A Clinical Trial of Docetaxel and Oxaliplatin in Patients With Recurrent or Metastatic Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Recurrent Breast Cancer|Metastatic Breast Cancer
Interventions: DRUG: docetaxel/ oxaliplatin
Sponsor: Korean Breast Cancer Study Group